A detailed history of Vanguard Group Inc transactions in Alector, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,455,727 shares of ALEC stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,455,727
Previous 5,320,970 2.53%
Holding current value
$10.1 Million
Previous $24.2 Million 5.47%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.34 - $6.58 $584,845 - $886,701
134,757 Added 2.53%
5,455,727 $25.5 Million
Q2 2024

Aug 13, 2024

BUY
$4.19 - $6.23 $1.71 Million - $2.54 Million
408,392 Added 8.31%
5,320,970 $24.2 Million
Q1 2024

May 10, 2024

BUY
$5.69 - $8.08 $2.99 Million - $4.25 Million
526,037 Added 11.99%
4,912,578 $29.6 Million
Q4 2023

Feb 14, 2024

SELL
$3.77 - $8.39 $4.28 Million - $9.52 Million
-1,134,367 Reduced 20.55%
4,386,541 $35 Million
Q3 2023

Nov 14, 2023

SELL
$5.2 - $8.77 $5.76 Million - $9.71 Million
-1,107,318 Reduced 16.71%
5,520,908 $35.8 Million
Q2 2023

Aug 14, 2023

BUY
$5.86 - $7.93 $1.31 Million - $1.78 Million
224,063 Added 3.5%
6,628,226 $39.8 Million
Q1 2023

May 15, 2023

BUY
$5.85 - $9.84 $231,379 - $389,191
39,552 Added 0.62%
6,404,163 $39.6 Million
Q4 2022

Feb 10, 2023

BUY
$6.88 - $9.55 $4.21 Million - $5.84 Million
611,417 Added 10.63%
6,364,611 $58.7 Million
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $364,438 - $587,373
44,498 Added 0.78%
5,753,194 $54.4 Million
Q2 2022

Aug 12, 2022

BUY
$7.65 - $14.24 $2.03 Million - $3.77 Million
264,773 Added 4.86%
5,708,696 $58 Million
Q1 2022

May 13, 2022

SELL
$13.02 - $20.78 $1.25 Million - $2 Million
-96,317 Reduced 1.74%
5,443,923 $77.6 Million
Q4 2021

Feb 14, 2022

BUY
$19.35 - $25.54 $8.96 Million - $11.8 Million
462,807 Added 9.11%
5,540,240 $114 Million
Q3 2021

Nov 12, 2021

BUY
$21.65 - $39.49 $3.16 Million - $5.77 Million
146,113 Added 2.96%
5,077,433 $116 Million
Q2 2021

Aug 13, 2021

BUY
$15.5 - $22.48 $76.4 Million - $111 Million
4,931,320 New
4,931,320 $103 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $154M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.